Form 4: Roivant Sciences CEO Matthew Gline Reports Share Disposal for Tax Obligations
SEC Form 4 Filing
Matthew Gline, CEO of Roivant Sciences, disposed of 10,945 common shares on April 20, 2024, to cover tax withholding obligations related to vested RSUs.
Summary
- On April 20, 2024, Matthew Gline, the CEO of Roivant Sciences Ltd., disposed of 10,945 common shares.
- The transaction was executed to cover tax withholding obligations associated with the vesting and settlement of previously granted Restricted Stock Units (RSUs).
- The shares were disposed of at a price of $10.46 per share.
- Following the transaction, Gline directly owns 1,153,706 common shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing represents a routine transaction for tax purposes and doesn't indicate any significant change in the executive's position or the company's outlook.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, such as directors and officers. This filing indicates a routine transaction related to tax obligations and doesn't necessarily reflect a change in the executive's long-term outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 04/20/2024 | Date of the transaction where 10,945 common shares were disposed of. |
| 04/23/2024 | Date of signature by Jo Chen, as Attorney-in-Fact for Matthew Gline. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.